Renalytix Plc (FRA:2O9)
0.0660
+0.0005 (0.76%)
Last updated: Jan 29, 2026, 9:55 AM CET
Renalytix Market Cap
Renalytix has a market cap or net worth of €29.02 million as of January 30, 2026. Its market cap has decreased by -36.96% in one year.
Market Cap
29.02M
Enterprise Value
32.89M
Revenue
2.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.07
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 74.02M to 29.02M, a decrease of -60.80%. That is a compound annual growth rate of -12.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 29.02M | -1.82% |
| Dec 31, 2025 | 29.56M | -31.35% |
| Dec 31, 2024 | 43.05M | 141.21% |
| Dec 29, 2023 | 17.85M | -70.84% |
| Dec 30, 2022 | 61.21M | -88.53% |
| Dec 31, 2021 | 533.78M | 36.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 40.70M |
| U.C.A. Aktiengesellschaft | 40.20M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 28.58M |
| Rubean AG | 27.29M |